Literature DB >> 34074532

Xenopus as a platform for discovery of genes relevant to human disease.

Valentyna Kostiuk1, Mustafa K Khokha2.   

Abstract

Congenital birth defects result from an abnormal development of an embryo and have detrimental effects on children's health. Specifically, congenital heart malformations are a leading cause of death among pediatric patients and often require surgical interventions within the first year of life. Increased efforts to navigate the human genome provide an opportunity to discover multiple candidate genes in patients suffering from birth defects. These efforts, however, fail to provide an explanation regarding the mechanisms of disease pathogenesis and emphasize the need for an efficient platform to screen candidate genes. Xenopus is a rapid, cost effective, high-throughput vertebrate organism to model the mechanisms behind human disease. This review provides numerous examples describing the successful use of Xenopus to investigate the contribution of patient mutations to complex phenotypes including congenital heart disease and heterotaxy. Moreover, we describe a variety of unique methods that allow us to rapidly recapitulate patients' phenotypes in frogs: gene knockout and knockdown strategies, the use of fate maps for targeted manipulations, and novel imaging modalities. The combination of patient genomics data and the functional studies in Xenopus will provide necessary answers to the patients suffering from birth defects. Furthermore, it will allow for the development of better diagnostic methods to ensure early detection and intervention. Finally, with better understanding of disease pathogenesis, new treatment methods can be tailored specifically to address patient's phenotype and genotype.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Birth defects; Congenital malformations; Disease model; Gene discovery; Mechanisms of organogenesis; Xenopus

Mesh:

Year:  2021        PMID: 34074532      PMCID: PMC8734201          DOI: 10.1016/bs.ctdb.2021.03.005

Source DB:  PubMed          Journal:  Curr Top Dev Biol        ISSN: 0070-2153            Impact factor:   4.897


  83 in total

1.  Histone H2B monoubiquitination regulates heart development via epigenetic control of cilia motility.

Authors:  Andrew Robson; Svetlana Z Makova; Syndi Barish; Samir Zaidi; Sameet Mehta; Jeffrey Drozd; Sheng Chih Jin; Bruce D Gelb; Christine E Seidman; Wendy K Chung; Richard P Lifton; Mustafa K Khokha; Martina Brueckner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

Review 2.  The nuclear pore complex: understanding its function through structural insight.

Authors:  Martin Beck; Ed Hurt
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-21       Impact factor: 94.444

3.  The formation of the mesoderm in urodelean amphibians : I. Induction by the endoderm.

Authors:  P D Nieuwkoop
Journal:  Wilhelm Roux Arch Entwickl Mech Org       Date:  1969-12

4.  Wnt antagonism initiates cardiogenesis in Xenopus laevis.

Authors:  V A Schneider; M Mercola
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

5.  Production of transgenic Xenopus laevis by restriction enzyme mediated integration and nuclear transplantation.

Authors:  Enrique Amaya; Kristen Kroll
Journal:  J Vis Exp       Date:  2010-08-21       Impact factor: 1.355

6.  Navigating the Xenopus tropicalis genome.

Authors:  Ira L Blitz
Journal:  Methods Mol Biol       Date:  2012

7.  The MLC1v gene provides a transgenic marker of myocardium formation within developing chambers of the Xenopus heart.

Authors:  Stuart J Smith; Paris Ataliotis; Surendra Kotecha; Norma Towers; Duncan B Sparrow; Timothy J Mohun
Journal:  Dev Dyn       Date:  2005-04       Impact factor: 3.780

Review 8.  Mechanisms of left-right asymmetry and patterning: driver, mediator and responder.

Authors:  Hiroshi Hamada; Patrick P L Tam
Journal:  F1000Prime Rep       Date:  2014-12-01

9.  A transgenic Xenopus laevis reporter model to study lymphangiogenesis.

Authors:  Annelii Ny; Wouter Vandevelde; Philipp Hohensinner; Manu Beerens; Ilse Geudens; Antonio Diez-Juan; Katleen Brepoels; Stéphane Plaisance; Paul A Krieg; Tobias Langenberg; Stefan Vinckier; Aernout Luttun; Peter Carmeliet; Mieke Dewerchin
Journal:  Biol Open       Date:  2013-07-11       Impact factor: 2.422

10.  Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands.

Authors:  Sheng Chih Jin; Jason Homsy; Samir Zaidi; Qiongshi Lu; Sarah Morton; Steven R DePalma; Xue Zeng; Hongjian Qi; Weni Chang; Michael C Sierant; Wei-Chien Hung; Shozeb Haider; Junhui Zhang; James Knight; Robert D Bjornson; Christopher Castaldi; Irina R Tikhonoa; Kaya Bilguvar; Shrikant M Mane; Stephan J Sanders; Seema Mital; Mark W Russell; J William Gaynor; John Deanfield; Alessandro Giardini; George A Porter; Deepak Srivastava; Cecelia W Lo; Yufeng Shen; W Scott Watkins; Mark Yandell; H Joseph Yost; Martin Tristani-Firouzi; Jane W Newburger; Amy E Roberts; Richard Kim; Hongyu Zhao; Jonathan R Kaltman; Elizabeth Goldmuntz; Wendy K Chung; Jonathan G Seidman; Bruce D Gelb; Christine E Seidman; Richard P Lifton; Martina Brueckner
Journal:  Nat Genet       Date:  2017-10-09       Impact factor: 38.330

View more
  1 in total

Review 1.  PCD Genes-From Patients to Model Organisms and Back to Humans.

Authors:  Michal Niziolek; Marta Bicka; Anna Osinka; Zuzanna Samsel; Justyna Sekretarska; Martyna Poprzeczko; Rafal Bazan; Hanna Fabczak; Ewa Joachimiak; Dorota Wloga
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.